Dimensional Fund Advisors’s Protara Therapeutics TARA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $258K | Buy |
85,303
+15,700
| +23% | +$47.5K | ﹤0.01% | 3082 |
|
|
2025
Q1 | $297K | Buy |
69,603
+48,606
| +231% | +$208K | ﹤0.01% | 3080 |
|
|
2024
Q4 | $111K | Buy |
+20,997
| New | +$111K | ﹤0.01% | 3232 |
|
|
2024
Q2 | – | Sell |
-12,126
| Closed | -$48.6K | – | 3406 |
|
|
2024
Q1 | $48.6K | Buy |
+12,126
| New | +$48.6K | ﹤0.01% | 3333 |
|
|
2023
Q4 | – | Sell |
-13,821
| Closed | -$23.1K | – | 3453 |
|
|
2023
Q3 | $23.1K | Sell |
13,821
-4,931
| -26% | -$8.24K | ﹤0.01% | 3436 |
|
|
2023
Q2 | $44.8K | Buy |
18,752
+1,918
| +11% | +$4.58K | ﹤0.01% | 3415 |
|
|
2023
Q1 | $52.2K | Hold |
16,834
| – | – | ﹤0.01% | 3380 |
|
|
2022
Q4 | $45 | Buy |
16,834
+1,052
| +7% | +$3 | ﹤0.01% | 3401 |
|
|
2022
Q3 | $47K | Sell |
15,782
-12,918
| -45% | -$38.5K | ﹤0.01% | 3411 |
|
|
2022
Q2 | $84K | Sell |
28,700
-1,906
| -6% | -$5.58K | ﹤0.01% | 3349 |
|
|
2022
Q1 | $156K | Sell |
30,606
-2,868
| -9% | -$14.6K | ﹤0.01% | 3341 |
|
|
2021
Q4 | $226K | Buy |
+33,474
| New | +$226K | ﹤0.01% | 3326 |
|
|
2018
Q3 | – | Sell |
-18,561
| Closed | -$45K | – | 3437 |
|
|
2018
Q2 | $45K | Hold |
18,561
| – | – | ﹤0.01% | 3341 |
|
|
2018
Q1 | $46K | Hold |
18,561
| – | – | ﹤0.01% | 3316 |
|
|
2017
Q4 | $35K | Hold |
18,561
| – | – | ﹤0.01% | 3310 |
|
|
2017
Q3 | $37K | Buy |
+18,561
| New | +$37K | ﹤0.01% | 3312 |
|